Logo image of 1SHL.MI

SIEMENS HEALTHINEERS AG (1SHL.MI) Stock Fundamental Analysis

Europe - Euronext Milan - BIT:1SHL - DE000SHL1006 - Common Stock

43.74 EUR
+0.5 (+1.16%)
Last: 11/14/2025, 7:00:00 PM
Fundamental Rating

5

Overall 1SHL gets a fundamental rating of 5 out of 10. We evaluated 1SHL against 63 industry peers in the Health Care Equipment & Supplies industry. 1SHL has a medium profitability rating, but doesn't score so well on its financial health evaluation. 1SHL is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year 1SHL was profitable.
In the past year 1SHL had a positive cash flow from operations.
1SHL had positive earnings in each of the past 5 years.
1SHL had a positive operating cash flow in each of the past 5 years.
1SHL.MI Yearly Net Income VS EBIT VS OCF VS FCF1SHL.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

With a decent Return On Assets value of 4.83%, 1SHL is doing good in the industry, outperforming 65.57% of the companies in the same industry.
Looking at the Return On Equity, with a value of 11.88%, 1SHL is in the better half of the industry, outperforming 68.85% of the companies in the same industry.
The Return On Invested Capital of 1SHL (7.65%) is better than 62.30% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1SHL is below the industry average of 9.81%.
The 3 year average ROIC (6.28%) for 1SHL is below the current ROIC(7.65%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.83%
ROE 11.88%
ROIC 7.65%
ROA(3y)4.09%
ROA(5y)4.11%
ROE(3y)10.3%
ROE(5y)10.39%
ROIC(3y)6.28%
ROIC(5y)6.22%
1SHL.MI Yearly ROA, ROE, ROIC1SHL.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

1.3 Margins

1SHL has a better Profit Margin (9.17%) than 65.57% of its industry peers.
In the last couple of years the Profit Margin of 1SHL has remained more or less at the same level.
1SHL has a Operating Margin of 13.53%. This is in the better half of the industry: 1SHL outperforms 62.30% of its industry peers.
In the last couple of years the Operating Margin of 1SHL has remained more or less at the same level.
1SHL has a Gross Margin of 38.63%. This is in the lower half of the industry: 1SHL underperforms 78.69% of its industry peers.
In the last couple of years the Gross Margin of 1SHL has remained more or less at the same level.
Industry RankSector Rank
OM 13.53%
PM (TTM) 9.17%
GM 38.63%
OM growth 3Y0.16%
OM growth 5Y0.1%
PM growth 3Y-0.76%
PM growth 5Y-1.23%
GM growth 3Y1.02%
GM growth 5Y0.02%
1SHL.MI Yearly Profit, Operating, Gross Margins1SHL.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1SHL is creating some value.
1SHL has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, 1SHL has more shares outstanding
Compared to 1 year ago, 1SHL has an improved debt to assets ratio.
1SHL.MI Yearly Shares Outstanding1SHL.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
1SHL.MI Yearly Total Debt VS Total Assets1SHL.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.2 Solvency

1SHL has an Altman-Z score of 2.03. This is not the best score and indicates that 1SHL is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of 1SHL (2.03) is comparable to the rest of the industry.
The Debt to FCF ratio of 1SHL is 5.45, which is a neutral value as it means it would take 1SHL, 5.45 years of fcf income to pay off all of its debts.
1SHL has a Debt to FCF ratio (5.45) which is comparable to the rest of the industry.
1SHL has a Debt/Equity ratio of 0.63. This is a neutral value indicating 1SHL is somewhat dependend on debt financing.
1SHL has a Debt to Equity ratio of 0.63. This is in the lower half of the industry: 1SHL underperforms 73.77% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 5.45
Altman-Z 2.03
ROIC/WACC1.22
WACC6.26%
1SHL.MI Yearly LT Debt VS Equity VS FCF1SHL.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

1SHL has a Current Ratio of 1.11. This is a normal value and indicates that 1SHL is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of 1SHL (1.11) is worse than 72.13% of its industry peers.
A Quick Ratio of 0.79 indicates that 1SHL may have some problems paying its short term obligations.
With a Quick ratio value of 0.79, 1SHL is not doing good in the industry: 72.13% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 0.79
1SHL.MI Yearly Current Assets VS Current Liabilites1SHL.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

5

3. Growth

3.1 Past

1SHL shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.17%.
The Earnings Per Share has been growing by 11.29% on average over the past years. This is quite good.
1SHL shows a small growth in Revenue. In the last year, the Revenue has grown by 4.53%.
The Revenue has been growing by 10.08% on average over the past years. This is quite good.
EPS 1Y (TTM)7.17%
EPS 3Y1.29%
EPS 5Y11.29%
EPS Q2Q%1.49%
Revenue 1Y (TTM)4.53%
Revenue growth 3Y2.49%
Revenue growth 5Y10.08%
Sales Q2Q%-0.11%

3.2 Future

1SHL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.43% yearly.
The Revenue is expected to grow by 5.04% on average over the next years.
EPS Next Y6.78%
EPS Next 2Y9.66%
EPS Next 3Y11.45%
EPS Next 5Y11.43%
Revenue Next Year4.22%
Revenue Next 2Y5.11%
Revenue Next 3Y6.41%
Revenue Next 5Y5.04%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1SHL.MI Yearly Revenue VS Estimates1SHL.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B
1SHL.MI Yearly EPS VS Estimates1SHL.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 18.30, 1SHL is valued on the expensive side.
1SHL's Price/Earnings ratio is rather cheap when compared to the industry. 1SHL is cheaper than 80.33% of the companies in the same industry.
When comparing the Price/Earnings ratio of 1SHL to the average of the S&P500 Index (26.59), we can say 1SHL is valued slightly cheaper.
With a Price/Forward Earnings ratio of 17.14, 1SHL is valued on the expensive side.
63.93% of the companies in the same industry are more expensive than 1SHL, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.80. 1SHL is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 18.3
Fwd PE 17.14
1SHL.MI Price Earnings VS Forward Price Earnings1SHL.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, 1SHL is valued a bit cheaper than 62.30% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, 1SHL is valued a bit cheaper than the industry average as 78.69% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 18.18
EV/EBITDA 13.75
1SHL.MI Per share data1SHL.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
1SHL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.7
PEG (5Y)1.62
EPS Next 2Y9.66%
EPS Next 3Y11.45%

6

5. Dividend

5.1 Amount

1SHL has a Yearly Dividend Yield of 2.30%.
Compared to an average industry Dividend Yield of 2.14, 1SHL pays a better dividend. On top of this 1SHL pays more dividend than 81.97% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.31, 1SHL has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.3%

5.2 History

The dividend of 1SHL has a limited annual growth rate of 4.33%.
Dividend Growth(5Y)4.33%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

49.72% of the earnings are spent on dividend by 1SHL. This is a bit on the high side, but may be sustainable.
1SHL's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP49.72%
EPS Next 2Y9.66%
EPS Next 3Y11.45%
1SHL.MI Yearly Income VS Free CF VS Dividend1SHL.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
1SHL.MI Dividend Payout.1SHL.MI Dividend Payout, showing the Payout Ratio.1SHL.MI Dividend Payout.PayoutRetained Earnings

SIEMENS HEALTHINEERS AG

BIT:1SHL (11/14/2025, 7:00:00 PM)

43.74

+0.5 (+1.16%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)02-05 2026-02-05
Inst Owners12.27%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap49.34B
Revenue(TTM)23.38B
Net Income(TTM)2.14B
Analysts82.96
Price Target56.87 (30.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.3%
Yearly Dividend0.95
Dividend Growth(5Y)4.33%
DP49.72%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.69%
Min EPS beat(2)-3.98%
Max EPS beat(2)13.36%
EPS beat(4)2
Avg EPS beat(4)3.9%
Min EPS beat(4)-3.98%
Max EPS beat(4)13.36%
EPS beat(8)5
Avg EPS beat(8)4.19%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)10
Avg EPS beat(16)2.88%
Revenue beat(2)0
Avg Revenue beat(2)-2.43%
Min Revenue beat(2)-4.1%
Max Revenue beat(2)-0.77%
Revenue beat(4)2
Avg Revenue beat(4)-0.83%
Min Revenue beat(4)-4.1%
Max Revenue beat(4)1.29%
Revenue beat(8)2
Avg Revenue beat(8)-1.21%
Revenue beat(12)3
Avg Revenue beat(12)-0.98%
Revenue beat(16)7
Avg Revenue beat(16)-0.37%
PT rev (1m)-8.23%
PT rev (3m)-8.1%
EPS NQ rev (1m)-9.25%
EPS NQ rev (3m)-9.25%
EPS NY rev (1m)-2.35%
EPS NY rev (3m)-2.51%
Revenue NQ rev (1m)1.21%
Revenue NQ rev (3m)1.34%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)-0.35%
Valuation
Industry RankSector Rank
PE 18.3
Fwd PE 17.14
P/S 2.11
P/FCF 18.18
P/OCF 13.97
P/B 2.73
P/tB N/A
EV/EBITDA 13.75
EPS(TTM)2.39
EY5.46%
EPS(NY)2.55
Fwd EY5.83%
FCF(TTM)2.41
FCFY5.5%
OCF(TTM)3.13
OCFY7.16%
SpS20.72
BVpS15.99
TBVpS-4.95
PEG (NY)2.7
PEG (5Y)1.62
Graham Number29.33
Profitability
Industry RankSector Rank
ROA 4.83%
ROE 11.88%
ROCE 9.97%
ROIC 7.65%
ROICexc 8.31%
ROICexgc 43.54%
OM 13.53%
PM (TTM) 9.17%
GM 38.63%
FCFM 11.61%
ROA(3y)4.09%
ROA(5y)4.11%
ROE(3y)10.3%
ROE(5y)10.39%
ROIC(3y)6.28%
ROIC(5y)6.22%
ROICexc(3y)6.78%
ROICexc(5y)6.63%
ROICexgc(3y)34.62%
ROICexgc(5y)34.83%
ROCE(3y)8.18%
ROCE(5y)8.09%
ROICexgc growth 3Y13.77%
ROICexgc growth 5Y12.12%
ROICexc growth 3Y9.41%
ROICexc growth 5Y-1.08%
OM growth 3Y0.16%
OM growth 5Y0.1%
PM growth 3Y-0.76%
PM growth 5Y-1.23%
GM growth 3Y1.02%
GM growth 5Y0.02%
F-Score8
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 5.45
Debt/EBITDA 2.54
Cap/Depr 63.12%
Cap/Sales 3.5%
Interest Coverage 7.04
Cash Conversion 79.23%
Profit Quality 126.59%
Current Ratio 1.11
Quick Ratio 0.79
Altman-Z 2.03
F-Score8
WACC6.26%
ROIC/WACC1.22
Cap/Depr(3y)57.95%
Cap/Depr(5y)60.43%
Cap/Sales(3y)3.49%
Cap/Sales(5y)3.63%
Profit Quality(3y)107.05%
Profit Quality(5y)106.62%
High Growth Momentum
Growth
EPS 1Y (TTM)7.17%
EPS 3Y1.29%
EPS 5Y11.29%
EPS Q2Q%1.49%
EPS Next Y6.78%
EPS Next 2Y9.66%
EPS Next 3Y11.45%
EPS Next 5Y11.43%
Revenue 1Y (TTM)4.53%
Revenue growth 3Y2.49%
Revenue growth 5Y10.08%
Sales Q2Q%-0.11%
Revenue Next Year4.22%
Revenue Next 2Y5.11%
Revenue Next 3Y6.41%
Revenue Next 5Y5.04%
EBIT growth 1Y12.53%
EBIT growth 3Y2.65%
EBIT growth 5Y10.19%
EBIT Next Year40.06%
EBIT Next 3Y18.71%
EBIT Next 5Y13.72%
FCF growth 1Y27.42%
FCF growth 3Y18%
FCF growth 5Y14.63%
OCF growth 1Y24.98%
OCF growth 3Y12.15%
OCF growth 5Y12.87%

SIEMENS HEALTHINEERS AG / 1SHL.MI FAQ

What is the ChartMill fundamental rating of SIEMENS HEALTHINEERS AG (1SHL.MI) stock?

ChartMill assigns a fundamental rating of 5 / 10 to 1SHL.MI.


What is the valuation status for 1SHL stock?

ChartMill assigns a valuation rating of 5 / 10 to SIEMENS HEALTHINEERS AG (1SHL.MI). This can be considered as Fairly Valued.


How profitable is SIEMENS HEALTHINEERS AG (1SHL.MI) stock?

SIEMENS HEALTHINEERS AG (1SHL.MI) has a profitability rating of 6 / 10.


What is the financial health of SIEMENS HEALTHINEERS AG (1SHL.MI) stock?

The financial health rating of SIEMENS HEALTHINEERS AG (1SHL.MI) is 3 / 10.


What is the earnings growth outlook for SIEMENS HEALTHINEERS AG?

The Earnings per Share (EPS) of SIEMENS HEALTHINEERS AG (1SHL.MI) is expected to grow by 6.78% in the next year.